Exploring the potential value of SRC in pan cancer based on bioinformatics methods.

Area of Science:

• Oncology
• Molecular Biology
• Immunology

Background:

• Tyrosine-Protein Kinase Src (SRC) is vital for cell signaling pathways.
• SRC dysregulation correlates with advanced cancers and poor prognosis.
• The prognostic value and immune role of SRC across diverse cancers are not fully understood.

Purpose of the Study:

• To investigate SRC expression in various cancers.
• To determine the prognostic significance of SRC in pan-cancer analysis.
• To explore SRC's relationship with the tumor immune microenvironment.

Main Methods:

• Utilized the Sangerbox database for differential SRC expression analysis.
• Performed Cox risk ratio and Kaplan-Meier analyses for survival outcomes.
• Assessed SRC's association with immune genes, mutation load, and microsatellite instability.

Main Results:

• SRC expression is upregulated in multiple tumor types compared to normal tissues.
• SRC levels correlate with overall survival (OS) in specific cancers (e.g., LIHC, PRAD).
• SRC is associated with tumor mutation burden, microsatellite instability, and immune cell infiltration in various cancers.

Conclusions:

• SRC may serve as a prognostic biomarker and therapeutic target in oncology.
• SRC expression is linked to immune infiltration and influences cancer patient prognosis.
• SRC warrants further investigation for its role in cancer development and immune response.